Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Martin, Anne"'
Autor:
Sandoval JL; Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Oncology, Department of Oncology, Geneva University Hospitals, Geneva, Switzerland., Franzoi MA; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France., di Meglio A; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.; Medical Oncology Department, Gustave Roussy Institute, Villejuif, France., Ferreira AR; Universidade Católica Portuguesa, Lisbon, Portugal., Viansone A; Medical Oncology Department, Gustave Roussy Institute, Villejuif, France., André F; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.; Medical Oncology Department, Gustave Roussy Institute, Villejuif, France., Martin AL; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France., Everhard S; UNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France., Jouannaud C; Institut Godinot, Reims, France., Fournier M; Institut Bergonié, Bordeaux, France., Rouanet P; Institut régional du Cancer de Montpellier-Val d'Aurelle, Montpellier, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Dhaini-Merimeche A; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandoeuvre lès Nancy, France., Sauterey B; Institut de Cancérologie de L'ouest-Site Angers, Angers, France., Cottu P; Institut Curie, Paris, France., Levy C; Centre François Baclesse, Caen, France., Stringhini S; Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Guessous I; Unit of Population Epidemiology, Division of Primary Care, Department of Health and Community Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Vaz-Luis I; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.; Interdisciplinary department for the Organization of Patient Pathways (DIOPP), Gustave Roussy Institute, Villejuif, France., Menvielle G; Unit of Molecular Predictors and New Targets in Oncology, INSERM, Gustave Roussy Institute, University Paris Saclay, Villejuif, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2908-2917. Date of Electronic Publication: 2024 Jun 18.
Autor:
Duivon M; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre Le Cancer, Centre François Baclesse, Normandie Université UNICAEN, 14000, Caen, France., Lequesne J; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre Le Cancer, Centre François Baclesse, Normandie Université UNICAEN, 14000, Caen, France.; Clinical Research Department, UNICANCER, Centre François Baclesse, 3 Av. du Général Harris, 14000, Caen, France.; Services Unit PLATON, Cancer and Cognition Platform, University of Caen Normandy, 14000, Caen, France., Di Meglio A; Cancer Survivorship Group, INSERM U981, Gustave Roussy, Villejuif, France., Pradon C; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Vaz-Luis I; Cancer Survivorship Group, INSERM U981, Gustave Roussy, Villejuif, France.; DIOPP, Gustave Roussy, Villejuif, France., Martin AL; UNICANCER, 75654, Paris, France., Everhard S; UNICANCER, 75654, Paris, France., Broutin S; Biological Resource Center, AMMICa, INSERM US23/CNRS UMS3655, Gustave Roussy, Villejuif, France., Rigal O; Care Support Department, Centre Henri Becquerel, 76000, Rouen, France.; Medical Oncology Department, Centre Henri Becquerel, 76000, Rouen, France., Bousrih C; Gustave Roussy, 94800, Villejuif, France., Lévy C; Institut Normand du Sein, Centre François Baclesse, 14000, Caen, France., Lerebours F; Medical Oncology Department, Institut Curie, 92210, Saint Cloud, France., Lange M; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre Le Cancer, Centre François Baclesse, Normandie Université UNICAEN, 14000, Caen, France. m.lange@baclesse.unicancer.fr.; Clinical Research Department, UNICANCER, Centre François Baclesse, 3 Av. du Général Harris, 14000, Caen, France. m.lange@baclesse.unicancer.fr.; Services Unit PLATON, Cancer and Cognition Platform, University of Caen Normandy, 14000, Caen, France. m.lange@baclesse.unicancer.fr., Joly F; ANTICIPE U1086 INSERM-UCN, Equipe Labellisée Ligue Contre Le Cancer, Centre François Baclesse, Normandie Université UNICAEN, 14000, Caen, France.; Clinical Research Department, UNICANCER, Centre François Baclesse, 3 Av. du Général Harris, 14000, Caen, France.; Services Unit PLATON, Cancer and Cognition Platform, University of Caen Normandy, 14000, Caen, France.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2024 Jun 05; Vol. 26 (1), pp. 93. Date of Electronic Publication: 2024 Jun 05.
Autor:
Franzoi MA; Cancer Survivorship Group, INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways, Gustave Roussy, Villejuif, France., Di Meglio A; Cancer Survivorship Group, INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France., Michiels S; Service de Biostatistique et d'Epidémiologie, Oncostat Inserm U1018, Université Paris-Saclay, Equipe Labellisée Ligue Contre le Cancer, Gustave Roussy, Villejuif, France., Gillanders E; Cancer Survivorship Group, INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France., Gaudin C; UNICANCER, Paris, France., Martin AL; UNICANCER, Paris, France., Vaz-Luis I; Cancer Survivorship Group, INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.; Department for the Organization of Patient Pathways, Gustave Roussy, Villejuif, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Feb 05; Vol. 7 (2), pp. e240688. Date of Electronic Publication: 2024 Feb 05.
Autor:
Kabirian R; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Sorbonne Université, Paris, France., Franzoi MA; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France., Havas J; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France., Coutant C; Centre Georges François Leclerc, Dijon, France., Tredan O; Centre Léon Bérard, Lyon, France., Levy C; Centre François Baclesse, Caen, France., Cottu P; Institut Curie, Paris, France., Dhaini Mérimèche A; Institut de Cancérologie de Lorraine-Alexis Vautrin, Vandœuvre-lès-Nancy, France.; Now with Centre Hospitalier de Lunéville-Ghemm, Pôle Mère-Enfant, Lunéville, France., Guillermet S; Centre Eugene-Marquis, Rennes, France., Ferrero JM; Centre Antoine Lacassagne, Nice, France., Giacchetti S; Hopital Saint Louis, Paris, France., Petit T; Centre Paul Strauss Centre de Lutte Contre le Cancer, Strasbourg, France., Dalenc F; Institut Claudius-Regaud, IUCT-Oncopole, Toulouse, France., Rouanet P; CRLC Val d'Aurelle, Montpellier, France., Everhard S; Unicancer, Paris, France., Martin AL; Unicancer, Paris, France., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Lambertini M; Department of Internal Medicine and Medical Specialties, School of Medicine University of Genova, Genova, Italy.; Department of Medical Oncology, UO Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vaz-Luis I; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.; Département Interdisciplinaire d'Organisation des Parcours Patients, Gustave Roussy, Villejuif, France., Di Meglio A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Nov 01; Vol. 6 (11), pp. e2343910. Date of Electronic Publication: 2023 Nov 01.
Autor:
Balazard F; Owkin Inc, New York, USA., Bertaut A; Centre George François Leclerc, Dijon, France., Bordet É; Sanofi Research and Development, Chilly-Mazarin, France., Mulard S; Owkin Inc, New York, USA., Blanc J; Centre George François Leclerc, Dijon, France., Briot N; Centre George François Leclerc, Dijon, France., Paux G; Sanofi Research and Development, Cambridge, MA, USA., Dhaini Merimeche A; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France., Rigal O; Centre Henri Becquerel, Rouen, France., Coutant C; Centre George François Leclerc, Dijon, France., Fournier M; Institut Bergonié, Bordeaux, France., Jouannaud C; Institut Jean Godinot Reims, France., Soulie P; Institut de Cancérologie de L'Ouest-Centre Paul Papin, Angers, France., Lerebours F; Institut Curie-Hôpital René Huguenin, Saint-Cloud, France., Cottu PH; Institut Curie-Site de Paris, Paris, France., Tredan O; Centre Léon Bérard, Lyon, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Levy C; Centre François Baclesse, Caen, France., Mouret-Reynier MA; Centre Jean-Perrin Clermont-Ferrand, France., Campone M; Institut de Cancérologie de l'Ouest-Centre René Gauducheau, Nantes Saint Herblain, France., Brady KJS; Sanofi Research and Development, Cambridge, MA, USA., Sasane M; Sanofi Research and Development, Cambridge, MA, USA., Rice M; Sanofi Research and Development, Cambridge, MA, USA., Coulouvrat C; Sanofi Research and Development, Chilly-Mazarin, France., Martin AL; Unicancer, Paris, France., Jacquet A; Unicancer, Paris, France., Vaz-Luis I; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Herold C; Sanofi Research and Development, Cambridge, MA, USA., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Department of Supportive care and pathways (DIOPP) Oncology, Gustave Roussy, Villejuif, France.; INSERM 981, Gustave Roussy, Villejuif, France.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Sep 07; Vol. 115 (9), pp. 1099-1108.
Autor:
Caumette E; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Sante Publique, Paris, France.; Department of Maieutics, Université de Montpellier, Montpellier, France., Di Meglio A; INSERM Unit U 981, Villejuif, France.; Breast Cancer Unit, Department of Cancer Medecine, Gustave Roussy, Villejuif, France., Vaz-Luis I; INSERM Unit U 981, Villejuif, France.; Breast Cancer Unit, Department of Cancer Medecine, Gustave Roussy, Villejuif, France., Charles C; Bordeaux Population Health Research Center (U1219), Université de Bordeaux, Bordeaux, France., Havas J; INSERM Unit U 981, Villejuif, France.; Breast Cancer Unit, Department of Cancer Medecine, Gustave Roussy, Villejuif, France.; Clinical Research Department, Gustave Roussy, Villejuif, France., de Azua GR; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Sante Publique, Paris, France., Martin E; INSERM Unit U 981, Villejuif, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Delaloge S; INSERM Unit U 981, Villejuif, France., Everhard S; Unicancer, Paris, France., Martin AL; Unicancer, Paris, France., Merimeche AD; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France., Rigal O; Centre Henri Becquerel, Rouen, France., Coutant C; Centre George François Leclerc, Dijon, France., Fournier M; Institut Bergonié, Bordeaux, France., Jouannaud C; Institut Jean Godinot Reims, Reims, France., Soulie P; Institut de Cancérologie de L'Ouest - Centre Paul Papin, Angers, France., Cottu PH; Institut Curie, Paris, France., Tredan O; Centre Léon Bérard, Lyon, France., Menvielle G; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie Et de Sante Publique, Paris, France., Dumas A; Université de Paris, ECEVE UMR 1123, INSERM (National Institute for Health and Medical Research), Paris, France. agnes.dumas@inserm.fr.
Publikováno v:
Journal of cancer survivorship : research and practice [J Cancer Surviv] 2023 Jun; Vol. 17 (3), pp. 694-705. Date of Electronic Publication: 2022 Mar 10.
Autor:
Soldato D; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy., Havas J; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Crane TE; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA., Presti D; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Lapidari P; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Rassy N; Medical Oncology, Gustave Roussy, Villejuif, France., Pistilli B; Medical Oncology, Gustave Roussy, Villejuif, France., Martin E; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Del Mastro L; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa, Italy.; Academic Unit of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Martin AL; UNICANCER, Paris, France., Jacquet A; UNICANCER, Paris, France., Coutant C; Medical Oncology, Centre Georges Francois Leclerc, Dijon, France., Cottu P; Medical Oncology, Institut Curie, Paris, France., Merimeche A; Medical Oncology, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France., Lerebours F; Medical Oncology, Institut Curie, Saint-Cloud, France., Tredan O; Medical Oncology, Centre Léon Bérard, Lyon, France., Vanlemmens L; Medical Oncology, Centre Oscar Lambret, Lille, France., André F; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Medical Oncology, Gustave Roussy, Villejuif, France., Vaz-Luis I; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Medical Oncology, Gustave Roussy, Villejuif, France., Di Meglio A; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.; Medical Oncology, Gustave Roussy, Villejuif, France.
Publikováno v:
Cancer [Cancer] 2022 Oct 01; Vol. 128 (19), pp. 3552-3563. Date of Electronic Publication: 2022 Aug 01.
Autor:
Di Meglio A; Medical Oncology, Gustave Roussy, Villejuif, France.; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., Havas J; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., Gbenou AS; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., Martin E; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., El-Mouhebb M; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., Pistilli B; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., Menvielle G; Sorbonne Université, INSERM, IPLESP, Paris, France., Dumas A; Université de Paris, ECEVE UMR 1123, INSERM, Paris, France., Everhard S; UNICANCER, Paris, France., Martin AL; UNICANCER, Paris, France., Cottu PH; Institut Curie, Paris, France., Lerebours F; Institut Curie Saint Cloud, Saint Cloud, France., Coutant C; Centre Georges-François Leclerc, Dijon, France., Lesur A; Institut de Cancérologie de Lorraine, Nancy, France., Tredan O; Centre Léon Bérard, Lyon, France., Soulie P; Centre Paul Papin, Angers, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Joly F; Centre Francois Baclesse, Caen, France., Delaloge S; Medical Oncology, Gustave Roussy, Villejuif, France., Ganz PA; University of California, Los Angeles, CA., André F; Medical Oncology, Gustave Roussy, Villejuif, France.; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France., Partridge AH; Dana-Farber Cancer Institute, Boston, MA., Jones LW; Memorial Sloan Kettering Cancer Center, New York, NY., Michiels S; Service de Biostatistique et d'Epidémiologie, Oncostat Inserm U1018, Université Paris- Saclay, Equipe labellisée Ligue Contre le Cancer, Gustave Roussy, Villejuif, France., Vaz-Luis I; Medical Oncology, Gustave Roussy, Villejuif, France.; INSERM Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Sep 20; Vol. 40 (27), pp. 3190-3204. Date of Electronic Publication: 2022 Apr 21.
Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
Autor:
de Calbiac O; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes and Angers, Saint-Herblain, France., Lusque A; Department of Biostatistics, Institut Claudius Regaud-IUCT Oncopole, Toulouse, France., Mailliez A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France., Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France., Emile G; Department of Medical Oncology, Centre François Baclesse, Caen, France., Jouannaud C; Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Patsouris A; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes and Angers, Angers, France., Diéras V; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Leheurteur M; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France., Cottu P; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France., Ferrero JM; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France., D'Hondt V; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France., Desmoulins I; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Mourato-Ribeiro J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Martin AL; Health Data and Partnerships Department, Unicancer, Paris, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes and Angers, Saint-Herblain, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Sep 01; Vol. 5 (9), pp. e2231170. Date of Electronic Publication: 2022 Sep 01.
Autor:
Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy., Massarotti C; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal, and Child Health, School of Medicine, University of Genova, Genova, Italy.; Academic Unit of Obstetrics and Gynaecology, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Havas J; Institut National de la Sante et de la Recherche Medicale Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France., Pistilli B; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Villejuif, France., Martin AL; Unicancer, Paris, France., Jacquet A; Unicancer, Paris, France., Coutant C; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France., Coussy F; Department of Medical Oncology, Institut Curie, Paris, France., Mérimèche AD; Department of Medical Oncology, Centre Alexis Vautrin, Vandoeuvre Les Nancy, France., Lerebours F; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Rousset-Jablonski C; Department of Surgery, Centre Léon Berard, Lyon, France., Jouannaud C; Department of Medical Oncology, Institut Jean Godinot, Reims, France., Rigal O; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Fournier M; Department of Surgical Oncology, Institut Bergonié, Bordeaux, France., Soulie P; Department of Medical Oncology, Institut de Cancérologie de L'ouest-Paul Papin, Angers, France., Franzoi MA; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Villejuif, France., Del Mastro L; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., André F; Institut National de la Sante et de la Recherche Medicale Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Villejuif, France., Vaz-Luis I; Institut National de la Sante et de la Recherche Medicale Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Villejuif, France., Di Meglio A; Institut National de la Sante et de la Recherche Medicale Unit 981, Molecular Predictors and New Targets in Oncology, Gustave Roussy, Villejuif, France.; Breast Cancer Unit, Medical Oncology Department, Gustave Roussy, Villejuif, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Sep 01; Vol. 5 (9), pp. e2233137. Date of Electronic Publication: 2022 Sep 01.